Quick Answer: Is It Normal to Plateau on Mounjaro?
Yes, a weight plateau while taking Mounjaro is common and well documented in clinical research, rather than simply being a commonly reported concern .
A 2025 analysis of the SURMOUNT-1 and SURMOUNT-4 trials found that most participants included in the analysis eventually reached a weight plateau, and that this is a normal part of the wider weight loss journey rather than proof that treatment has failed, or that Mounjaro has stopped working.
What varies enormously between individuals is when it happens often around 24 to 36 weeks, depending on factors such as starting BMI and how it looks day to day.
For adults in the UK who are using or considering Mounjaro for weight management, the key question is whether a slowdown is a genuine plateau or just normal fluctuation. This guide explains the difference, why plateaus happen biologically, when weight loss on Mounjaro may slow without signalling a problem, what practical steps can help you interpret and manage it, when to speak to your prescriber, and how NICE guidance approaches treatment reviews.
That matters because a plateau can feel as though the medication has stopped helping, when this may not necessarily be the case . Understanding what is expected during treatment can help you manage expectations, avoid unnecessary changes, and know when medical advice is actually needed.
What Counts as a Mounjaro Weight Loss Plateau, vs Normal Fluctuation
It is worth distinguishing a genuine plateau from ordinary week-to-week weight fluctuation, since the two get confused easily.
A few weeks of broadly unchanged weight can feel like a stall, but this is not necessarily a genuine plateau. Many people describe their weight loss as having stalled when their weight remains broadly unchanged for four or more consecutive weeks , even though stricter trial definitions are longer.
Day-to-day changes from water retention, hormonal cycles, digestion, or even how much salt you have eaten are not a plateau, they are normal fluctuations that happen regardless of treatment.
Researchers studying tirzepatide have used more specific definitions of a weight plateau, including periods of 12 weeks during which body weight changes by less than 5% , defined as less than 5% weight change over a 12-week interval and all subsequent 12-week intervals.
Shorter stalls of around 3–4 weeks are often discussed informally and are not the same as proof treatment has failed. That's a considerably longer, more sustained pattern than a couple of static weeks on the scales, which is often just normal variation.
Progress should also be judged by waist circumference or fitness changes, not only body weight on the scale.
When Do Plateaus Typically Happen? What the Evidence Shows
The most relevant evidence comes from a 2025 post-hoc analysis of the SURMOUNT-1 and SURMOUNT-4 trials, published in the journal Clinical Obesity, which specifically investigated time to weight plateau in people treated with tirzepatide.
Broader Mounjaro clinical trial results reported average weight reductions of approximately 15–20% over 72 weeks, depending on dose and study population .
The findings showed considerable variation depending on individual factors, particularly starting with the BMI category.
Median time to plateau varied by baseline BMI category in the study, while multivariable analysis found that higher tirzepatide doses, younger age and female sex were associated with a longer time to plateau.
In some clinical trial groups, average weight reduction approached 20–22%, depending on dose and study design , which helps explain why a slowdown often happens after substantial progress rather than at the very start.
This is genuinely useful context: there's no single universal "week X" when plateaus happen for everyone, and if you are plateauing earlier or later than someone else you have read about online, that's consistent with the evidence, not a sign something's gone wrong specifically for you.
Why Plateaus Happen: The Biology and Metabolic Adaptation
A plateau does not necessarily mean that Mounjaro has lost effectiveness , it reflects your body reaching a new equilibrium as the body adapts.
As you lose weight, your body generally needs fewer calories to maintain its lower body weight, and metabolic adaptation may also contribute to a reduction in energy expenditure.
Changes in appetite regulation can also affect hunger and satiety as weight loss progresses.
In a DXA substudy of SURMOUNT-1, around 25% of weight lost with tirzepatide was lean mass, although lean mass is not the same as skeletal muscle.
This is sometimes described as the body shifting from a calorie deficit toward calorie balance; the gap that drove earlier weight loss narrows naturally as the body adjusts and metabolism slows, regardless of what medication you are taking.
Longer-term data from SURMOUNT-1 also found that most people who reached their lowest weight during treatment maintained it reasonably well over time, rather than losing further or regaining substantially, when they continued treatment.
In a three-year post-hoc analysis of treatment-adherent SURMOUNT-1 participants, around 70% had regained less than 5% of their lowest recorded weight by week 176.
Plateau vs Stopped Working: Are They the Same Thing?
Not quite, and the distinction matters for how you think about your own progress.
A plateau, as described above, is an expected phase where the rate of weight loss slows or levels off after a period of active loss, it does not mean Mounjaro has stopped having any effect, and ongoing fat loss may not always show up as immediate scale movement.
Its effects on appetite regulation, feelings of fullness and blood sugar control may continue even while body weight remains stable , and those changes can still influence energy intake, which is part of why many people maintain their weight successfully during a plateau rather than immediately regaining.
Genuinely losing effectiveness, sometimes described online as treatment "not working anymore," is a different and less common situation, and is not something to self-diagnose from forum posts or general online discussion.
If you are concerned your treatment genuinely is not working the way it used to, that is a conversation for your prescriber, who can assess your individual situation rather than compare it to anecdotal accounts from other people's very different circumstances.
Putting Weight Back On: Is This Different From a Plateau?
Yes, this is a different situation from a plateau and worth naming separately, since the keyword phrase "putting weight on" describes genuine weight gain rather than a stall. A plateau means weight staying roughly stable.
Weight gain while taking Mounjaro is different from a plateau and may warrant discussion with your prescriber, particularly if it is sustained or unexplained.
Since it may relate to factors such as changes in diet, activity, other medications, insulin resistance, or shifts in thyroid hormones, as well as other underlying health conditions that your prescriber can assess, rather than being an expected part of treatment. It is not something to assume is "just a plateau" without checking in.
What NICE Guidance Says About Reviewing Progress
NICE recommends assessing weight reduction after 6 months on the highest tolerated dose. If less than 5% of initial weight has been lost, the prescriber should discuss whether continuing treatment remains appropriate.
As a general benchmark, treatment response may be assessed by considering the percentage of weight lost while taking the highest tolerated dose . This isn't specifically a "plateau checkpoint," but it is a useful, official point in treatment where your prescriber will look at your overall trajectory, plateau or otherwise, and discuss whether continuing as before, adjusting your approach, or exploring other options makes sense for you.
What You Can Do During a Plateau
There are things within your control worth revisiting during a plateau, separate from anything your prescriber needs to be involved in:
- Reviewing whether portion sizes or snacking have crept up gradually by tracking food or calorie intake for a short period, which can help identify changes in portion sizes, snacking or overall energy intake. The unconscious portion drift often called calorie creep as appetite-suppressing effects feel less dramatic than they did early on.
- Checking whether physical activity levels have reduced compared with when you started treatment , and whether your exercise routine still includes regular exercise and resistance training such as lifting weights to build muscle, preserve lean muscle mass, burn more calories, and boost metabolism. Insufficient resistance training may contribute to loss of muscle mass during weight loss
- Being honest with yourself about consistency by reviewing your diet and exercise plan, including whether ultra processed foods have crept back in and whether your healthy diet still creates the calorie deficit you need
- Prioritising protein intake and fibre in meals, since both help maintain satiety, support diet and exercise, and preserve lean muscle mass during weight loss; inadequate protein can contribute to muscle breakdown
- Prioritising adequate sleep and managing stress may support appetite regulation, eating patterns and overall weight-management efforts.
- Giving a plateau time before making major changes, since a few static weeks is not the same as the sustained, longer pattern that counts as a genuine plateau
Maintaining adequate hydration may support general wellbeing during weight-loss treatment.
None of this is about blaming yourself, weight-loss plateaus can be a normal part of treatment, not a personal failing, but they are a useful prompt to revisit habits that may have quietly shifted since you started treatment. These adjustments may support ongoing weight-management efforts and help address factors that could be contributing to slower progress .
When to Talk to Your Prescriber About a Plateau
Consider discussing a plateau with your prescriber if it persists, if you are unsure whether it represents a genuine plateau, if you are experiencing sustained weight gain, or if you are considering changing your treatment.
This is also the right time to raise actual weight gain, rather than a plateau, since that's a different pattern worth investigating properly.
Should My Dose Change Because of a Plateau?
This is entirely a decision for your prescriber, based on your individual circumstances, and is not something to request or self-manage based on a plateau alone.
A plateau alone does not automatically mean that a higher dose is required or appropriate . Some people continue successfully on the same dose with lifestyle adjustments alone, while others may need a review based on their overall response.
If a dose change is being considered, your prescriber will weigh up your overall progress, tolerability, and individual response, not just the fact that the scale has stalled. For ongoing support with Mounjaro treatment, this is a normal thing to discuss at a routine check-in rather than something requiring an emergency consultation, and any decision to stay on your current dose or change it should be made with your prescriber.
Medical Disclaimer
This guide provides general information about weight-loss plateaus while taking Mounjaro (tirzepatide). It is not a substitute for personalised medical advice, diagnosis or treatment. Weight-loss patterns vary between individuals, and clinical trial findings do not predict exactly when or whether an individual will reach a plateau.
Do not change your Mounjaro dose or stop treatment because of a plateau without speaking to your prescriber. Your prescriber can assess your weight-loss progress, treatment response, side effects, other medicines and overall health before deciding whether any change is appropriate.
If you experience unexplained or sustained weight gain, significant side effects, or concerns that Mounjaro is no longer working as expected, speak to your prescriber or pharmacist. Always follow the prescribed dosing instructions and the advice of your healthcare professional.
